Back to
BlackRock, Inc.
LYEL5 quarters
Position history for
BlackRock, Inc.'s holdings in LYELL IMMUNOPHARMA INC
Yes. BlackRock holds 724,342 shares of LYEL (Lyell Immunopharma), worth $10.2M, as of its Q2 2026 13F filing. It increased the position from 191,820 shares in Q1 2026. BlackRock has held LYEL in every 13F on record since Q2 2025, 5 quarterly filings.
Current Value
$10.2M
Current Shares
724,342
Total Value Change
+$8.9M
Total Shares Change
+579,483
Quarter-by-Quarter History
Other major holders of LYEL: VANGUARD GROUP INC, VANGUARD CAPITAL MANAGEMENT LLC, CITADEL ADVISORS LLC